Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side ef...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | International Journal of Vascular Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/867964 |